NCT02768155View on ClinicalTrials.gov

Evaluation of Amniotic Fluid Product in Knee Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

July 31, 2017

Conditions
Osteoarthritis of the Knee
Interventions
OTHER

Amniotic Fluid 4.0ml dose

Injection of Amniotic Fluid

OTHER

Amniotic Fluid 2.0ml dose

Injection of Amniotic Fluid

OTHER

Placebo Control

Normal Saline

Trial Locations (2)

35205

Central Research Associates, Inc, Birmingham

60016

Weil Foot, Ankle and Orthopedic Institute, Des Plaines

All Listed Sponsors
lead

MiMedx Group, Inc.

INDUSTRY

NCT02768155 - Evaluation of Amniotic Fluid Product in Knee Osteoarthritis | Biotech Hunter | Biotech Hunter